ketoconazole has been researched along with Sicca Syndrome in 1 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aetiology of the atrophy is still unknown, and two main hypotheses have been formulated, one suggesting a correlation with long-term use of topical steroids and the other a delayed type hypersensitivity to epicutaneous antigens derived from components of the fungus." | 1.46 | Atrophic pityriasis versicolor occurring in a patient with Sjögren's syndrome. ( Alaibac, M; Marinello, E; Piaserico, S, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marinello, E | 1 |
| Piaserico, S | 1 |
| Alaibac, M | 1 |
1 other study available for ketoconazole and Sicca Syndrome
| Article | Year |
|---|---|
Atrophic pityriasis versicolor occurring in a patient with Sjögren's syndrome.
Topics: Administration, Cutaneous; Adult; Antifungal Agents; Atrophy; Female; Humans; Ketoconazole; Sjogren' | 2017 |